PharmAust Limited (PAA.AX)

ASX - ASX Delayed price. Currency in AUD

Add to watchlist

0.1650

0.0000

(0.00%)

As of 10:41AM AEST. Market open.

Loading interactive chart…

Simply Wall St.
PharmAust (ASX:PAA) shareholders have earned a 21% CAGR over the last five years
While PharmAust Limited ( ASX:PAA ) shareholders are probably generally happy, the stock hasn't had particularly good...
PR Newswire
PharmAust announces positive Phase 1 MEND Study Top-Line Results in MND / ALS
PharmAust Limited (ASX: PAA & PAAOA) ("PharmAust" or "the Company"), a clinical-stage biotechnology company, is pleased to announce that it has met its primary safety and tolerability endpoints with monepantel (MPL) and, importantly, demonstrated a positive signal of potential efficacy. Rates of disease progression in patients with Motor Neurone Disease (MND) / Amyotrophic Lateral Sclerosis (ALS) measured by changes in ALSFRS-R may be slowed by 58% for Cohort 2, when compared to an external cont
Simply Wall St.
PharmAust (ASX:PAA) delivers shareholders incredible 42% CAGR over 5 years, surging 11% in the last week alone
We think all investors should try to buy and hold high quality multi-year winners. And we've seen some truly amazing...